Press releases
These press releases are intended for business journalists and analysts/investors
New treatment reimbursed for major breathing disorder
Trelegy Ellipta (fluticasone furoate, umeclidinium and vilanterol) - first, once-daily triple therapy for COPD reimbursed by the PBS in Australia
Read more - New treatment reimbursed for major breathing disorder Read more
GSK statement on influenza vaccine supply for the 2018 season
Read more - GSK statement on influenza vaccine supply for the 2018 season Read more
Nominations open for prestigious GSK Award for Research Excellence
- 38th year of $80,000 research grant
Read more - Nominations open for prestigious GSK Award for Research Excellence Read more
Simon Dingemans, Chief Financial Officer, to retire from GSK
Read more - Simon Dingemans, Chief Financial Officer, to retire from GSK Read more
GSK Australia reports 2017 results to ASIC
Read more - GSK Australia reports 2017 results to ASIC Read more
GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER
Read more - GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER Read more
Discontinuation of Typherix adult vaccine
Read more - Discontinuation of Typherix adult vaccine Read more
GSK launches Discovery Fast Track: Australian Challenge in search of early drug discovery partnerships with local researchers
New report aims to broaden understanding of how new medicines are funded in Australia
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
